Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Drug Deliv ; 15(7): 972-978, 2018.
Article in English | MEDLINE | ID: mdl-29629659

ABSTRACT

OBJECTIVE: Gadolinium diethylenetriaminepentaacetic di[5-(4'-amidophenyl)-10,15,20- tris(4'-sulfonatophenyl) porphyrin trisodium salt] (Gd-DTPA-2APTSPP) was synthesized by the reaction of diethylenetriaminepentaacetic dianhydride with 5-(4'-aminophenyl)-10,15,20-tris(4'-sulfonatophenyl) porphyrin and subsequently chelation with gadolium chloride. METHODS: This gadolinium complex was characterized and its properties in vitro and in vivo were also evaluated. Compared with Gd-DTPA, Gd-DTPA-2APTSPP possessed high relaxivity r1, low cytotoxicity to HeLa cells and high enhanced signal intensities of the VX2 carcinoma in rabbits for a prolonged time. CONCLUSION: Moreover, Gd-DTPA-2APTSPP can distinguish the VX2 carcinoma from the reactive hyperplasia incited by inflammation and normal tissues in rabbits. Therefore, Gd-DTPA-2APTSPP can be taken up selectively by tumors and show the potential as a tumor-targeting MRI contrast agent.


Subject(s)
Contrast Media/administration & dosage , Gadolinium DTPA/administration & dosage , Gadolinium/administration & dosage , Neoplasms/diagnostic imaging , Porphyrins/administration & dosage , Animals , Cell Survival/drug effects , Contrast Media/chemistry , Gadolinium/chemistry , Gadolinium DTPA/chemistry , HeLa Cells , Humans , Magnetic Resonance Imaging , Porphyrins/chemistry , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...